17-plex imaging of renal cell carcinoma, acquired on the Orion platform. 📸
This image, courtesy of Gaurav Shrestha, PhD from Ohio State University is featured in the RareCyte 2026 Calendar.
➡️ View all images from our Calendar Contest: rarecyte.com/2026calendar...
#RareCyteCalendar #MultiplexIF
Live from #IO360Summit! 🎬 Thank you to everyone who attended our Orion Technology Showcase this morning.
Orion advances IO research by rapidly imaging the TME with sub-micron resolution, delivering ultra-fast, whole slide spatial insights.
👋 Stop by Booth #38
#SpatialBiology #MultiplexIF
Heading to #IO360Summit in Boston next week?
🗓️ Don’t miss the IO Novel Technologies Showcase B to discover how the Orion accelerates immuno-oncology research by profiling the tumor microenvironment with sub-micron resolution — all at high speed.
👋 Stop by Booth #38
#SpatialBiology #MultiplexIF
📣 Last chance to register! Join this webinar to learn how Orion captures 20 channels in a single round of imaging— simplifying panel design, enhancing data quality, and maximizing throughput.
Register Here: rarecyte.com/webinar-brea...
#SpatialBiology #SpatialProteomics #MultiplexIF
📽️ Register Today! Discover how single-round imaging using the Orion Spatial Imager is advancing spatial proteomics—delivering higher throughput, greater efficiency, and superior image quality.
Learn more and register today, rarecyte.com/webinar-brea...
#SpatialBiology #MultiplexIF
🗓️ Save the Date! Attend this webinar to explore how the Orion Spatial Imager is transforming #spatialproteomics with high throughput, single-round imaging—eliminating the need for cycling and improving image quality.
Register: rarecyte.zoom.us/webinar/regi...
#SpatialBiology #MultiplexIF #RareCyte
Everything #spatialomics - A hub for researchers, clinicians, companies, journals, and institutions exploring spatial omics technologies.
Leave a comment, if you’d like to join 🧬🙂
#SpatialOmics #Visium #Xenium #MERSCOPE #MultiplexIF #MIBI #OmicsResearch #Biotech #Innovation
go.bsky.app/zcDshW
3) GREAT DEBATE: Pre-treatment #predictive #biomarkers: INF-y vs. #Immunoscore vs. #multiplexIF /next-generation #spatialbiology. A 3-way debate. Jerome Galon’s turn. Immunoscore is validated and predicts response to neoadjuvant therapy/organ sparing in rectal CA #Bridge2024 @sitcancer.bsky.social
2) GREAT DEBATE: Pre-treatment #predictive #biomarkers: INF-y vs. #Immunoscore vs. #multiplexIF /next-generation #spatialbiology. A 3-way debate..
Drs. Christian Blank vs Jerome Galon vs Janis M. Taube. Dr Blank starts. IFNg sig improves 2 ID pts who need more Tx #Bridge2024 @sitcancer.bsky.social
1) GREAT DEBATE: Pre-treatment #predictive #biomarkers: INF-y vs. #Immunoscore vs. #multiplexIF /next-generation #spatialbiology. A 3-way debate..
Drs. Christian Blank vs Jerome Galon vs Janis M. Taube. Dr Blank starts. IFNg sig improves 2 ID pts who need more Tx #Bridge2024 @sitcancer.bsky.social
